Gabon  

African Region Office  
2,226,000 Population - 2024

Neighbouring Countries

  •
News
No data found!
Calendar
NP
NAPHS - Gabon Completed

06 - 10 September 2021

JE
Gabon v2.2019

-


Completed
2019

Strategic Risk Analysis and Profiling for Health Emergencies
WHO Health Emergency Dashboard
COVID-19; 2020 - Gabon
2020
Lowest Indicators
20 %

P.1.1 The State has assessed, adjusted and aligned its domestic legislation, policies and administrative arrangements in all

National Legislation, Policy and Financing (JEE)
20 %

P.1.2 Financing is available for the implementation of IHR capacities

National Legislation, Policy and Financing (JEE)
20 %

P.1.3 A financing mechanism and funds are available for timely response to public health emergencies

National Legislation, Policy and Financing (JEE)
20 %

P.2.1 A functional mechanism is established for the coordination and integration

IHR Coordination, Communication and Advocacy (JEE)
20 %

P.3.2 Surveillance of AMR

Antimicrobial Resistance (JEE)
20 %

P.3.3 Infection prevention and control

Antimicrobial Resistance (JEE)
20 %

P.3.4 Optimize use of antimicrobial medicines in human and animal health and agriculture

Antimicrobial Resistance (JEE)
20 %

P.4.1 Coordinated surveillance systems in place in the animal health and public health sectors for zoonotic diseases/pathogens

Zoonotic Disease (JEE)
20 %

P.4.2 Veterinary or Animal Health Workforce

Zoonotic Disease (JEE)
20 %

P.5.1 Surveillance systems in place for the detection and monitoring of foodborne diseases and food contamination

Food Safety (JEE)
20 %

P.5.2 Mechanisms are established and functioning for the response and management of food safety emergencies

Food Safety (JEE)
20 %

P.6.1 Whole-of-government biosafety and biosecurity system in place for all sectors (including human, animal and agriculture

Biosafety and Biosecurity (JEE)
20 %

P.6.2 Biosafety and biosecurity training and practices in all relevant sectors (including human, animal and agriculture)

Biosafety and Biosecurity (JEE)
20 %

P.7.1 Vaccine coverage (measles) as part of national program

Immunization (JEE)
20 %

D.1.1 Laboratory testing for detection of priority diseases

National Laboratory System (JEE)
20 %

D.1.2 Specimen referral and transport system

National Laboratory System (JEE)
20 %

D.1.3 Effective national diagnostic network

National Laboratory System (JEE)
20 %

R.1.1 Strategic emergency risk assessments conducted and emergency resources identified and mapped

Preparedness (JEE)
20 %

R.1.2 National multi-sectoral multi-hazard emergency preparedness measures, including emergency response plans, are developed

Preparedness (JEE)
20 %

R.2.1 Emergency response coordination

Emergency Response Operations (JEE)
20 %

R.2.2 Emergency operations centre (EOC) capacities, procedures and plans

Emergency Response Operations (JEE)
20 %

R.3.1 Public Health and Security Authorities, (e.g. Law Enforcement, Border Control, Customs)

Linking Public Health and Security Authorities (JEE)
20 %

R.4.1 System is in place for sending and receiving medical countermeasures during a public health emergency

Medical Countermeasures (JEE)
20 %

R.4.2 System is in place for sending and receiving health personnel during a public health emergency

Medical Countermeasures (JEE)
20 %

R.4.3 Case management procedures implemented for IHR relevant hazards

Medical Countermeasures (JEE)
20 %

R.5.1 Risk communication systems for unusual/unexpected events and emergencies

Risk Communication (JEE)
20 %

R.5.4 Communication Engagement with Affected Communities

Risk Communication (JEE)
20 %

PoE.1 Routine capacities are established at PoE

Points of Entry (PoEs) (JEE)
20 %

PoE.2 Effective Public Health Response at Points of Entry

Points of Entry (PoEs) (JEE)
20 %

CE.1 Mechanisms are established and functioning for detecting and responding to chemical events or emergencies

Chemical Events (JEE)
20 %

RE.1 Mechanisms are established and functioning for detecting and responding to radiological and nuclear emergencies.

Radiation Emergencies (JEE)
20 %

RE.2 Enabling environment in place for management of radiological and nuclear emergencies

Radiation Emergencies (JEE)
20 %

C.1.1 Policy, legal and normative instruments

C1.Policy, Legal and normative Instruments to implement IHR (SPAR)
20 %

C.1.2 Gender Equality in health emergencies

C1.Policy, Legal and normative Instruments to implement IHR (SPAR)
20 %

C.2.1 National IHR Focal Point functions

C2.IHR Coordination, National IHR Focal Point functions and advocacy (SPAR)
20 %

C.4.2 Implementation of a laboratory biosafety and biosecurity regime

C4.Laboratory (SPAR)
20 %

C.4.3 Laboratory quality system

C4.Laboratory (SPAR)
20 %

C.6.2 Workforce surge during a public health event

C6.Human resources (SPAR)
20 %

C.10.1 RCCE system for emergencies

C10.Risk communication and community engagement (RCCE) (SPAR)
20 %

C.10.2 Risk communication

C10.Risk communication and community engagement (RCCE) (SPAR)
20 %

C.10.3 Community engagement

C10.Risk communication and community engagement (RCCE) (SPAR)
20 %

C.11.2 Public health response at points of entry

C11.Points of entry (PoEs) and border health (SPAR)
20 %

C.13.1 Multisectoral collaboration mechanism for food safety events

C13.Food safety (SPAR)
20 %

P.1.1 The State has assessed, adjusted and aligned its domestic legislation, policies and administrative arrangements in all

National Legislation, Policy and Financing (JEE)
20 %

P.1.2 Financing is available for the implementation of IHR capacities

National Legislation, Policy and Financing (JEE)
20 %

P.1.3 A financing mechanism and funds are available for timely response to public health emergencies

National Legislation, Policy and Financing (JEE)
20 %

P.2.1 A functional mechanism is established for the coordination and integration

IHR Coordination, Communication and Advocacy (JEE)
20 %

P.3.2 Surveillance of AMR

Antimicrobial Resistance (JEE)
20 %

P.3.3 Infection prevention and control

Antimicrobial Resistance (JEE)
20 %

P.3.4 Optimize use of antimicrobial medicines in human and animal health and agriculture

Antimicrobial Resistance (JEE)
20 %

P.4.1 Coordinated surveillance systems in place in the animal health and public health sectors for zoonotic diseases/pathogens

Zoonotic Disease (JEE)
20 %

P.4.2 Veterinary or Animal Health Workforce

Zoonotic Disease (JEE)
20 %

P.5.1 Surveillance systems in place for the detection and monitoring of foodborne diseases and food contamination

Food Safety (JEE)
20 %

P.5.2 Mechanisms are established and functioning for the response and management of food safety emergencies

Food Safety (JEE)
20 %

P.6.1 Whole-of-government biosafety and biosecurity system in place for all sectors (including human, animal and agriculture

Biosafety and Biosecurity (JEE)
20 %

P.6.2 Biosafety and biosecurity training and practices in all relevant sectors (including human, animal and agriculture)

Biosafety and Biosecurity (JEE)
20 %

P.7.1 Vaccine coverage (measles) as part of national program

Immunization (JEE)
20 %

D.1.1 Laboratory testing for detection of priority diseases

National Laboratory System (JEE)
20 %

D.1.2 Specimen referral and transport system

National Laboratory System (JEE)
20 %

D.1.3 Effective national diagnostic network

National Laboratory System (JEE)
20 %

R.1.1 Strategic emergency risk assessments conducted and emergency resources identified and mapped

Preparedness (JEE)
20 %

R.1.2 National multi-sectoral multi-hazard emergency preparedness measures, including emergency response plans, are developed

Preparedness (JEE)
20 %

R.2.1 Emergency response coordination

Emergency Response Operations (JEE)
20 %

R.2.2 Emergency operations centre (EOC) capacities, procedures and plans

Emergency Response Operations (JEE)
20 %

R.3.1 Public Health and Security Authorities, (e.g. Law Enforcement, Border Control, Customs)

Linking Public Health and Security Authorities (JEE)
20 %

R.4.1 System is in place for sending and receiving medical countermeasures during a public health emergency

Medical Countermeasures (JEE)
20 %

R.4.2 System is in place for sending and receiving health personnel during a public health emergency

Medical Countermeasures (JEE)
20 %

R.4.3 Case management procedures implemented for IHR relevant hazards

Medical Countermeasures (JEE)
20 %

R.5.1 Risk communication systems for unusual/unexpected events and emergencies

Risk Communication (JEE)
20 %

R.5.4 Communication Engagement with Affected Communities

Risk Communication (JEE)
20 %

PoE.1 Routine capacities are established at PoE

Points of Entry (PoEs) (JEE)
20 %

PoE.2 Effective Public Health Response at Points of Entry

Points of Entry (PoEs) (JEE)
20 %

CE.1 Mechanisms are established and functioning for detecting and responding to chemical events or emergencies

Chemical Events (JEE)
20 %

RE.1 Mechanisms are established and functioning for detecting and responding to radiological and nuclear emergencies.

Radiation Emergencies (JEE)
20 %

RE.2 Enabling environment in place for management of radiological and nuclear emergencies

Radiation Emergencies (JEE)

47 %

Avg.score (15 capacities)
Submitted - 2023

SPAR

26%

Avg. score (19 capacities)
Latest completion - 2019

JEE

IHR Designated PoE
Ground Crossing
4
Port
3
Airport
3


No Data!

SimEx



No Data!

AAR

Completed

REMAP

Conducted
2022

IHR-PVS Bridging Workshop

3

Activities Conducted

2007 - 2011

WOAH PVS Pathway

Completed
2022

AMR Self Assessment



No Data!

MPC
Multisectoral Preparedness Coordination

Universal Health Coverage  
UHC 2030
N/A
UHC Partnership
Partner
UHC Service Coverage Index
SDg 3.8.1
49
Sustainable Development Goals  
Development assistance and vaccine coverage
SDG Target 3.b
3.13
Health workforce (Medical doctors per 10000 population)
SDG Target 3.c
6.241
Sanitation and hygiene Total Population using at least basic sanitation services (%)
SDG Target 6.2
50
Others


Completed
2021

NAPHS


No Plan or Plan not publicly available

0

Influenza Plan


C - National AMR action plan developed.

AMR PLAN


N/A

WHO HRP

Resource Landscape
DONOR
TECHNICAL AREA SUPPORTED
  • National Legislation, Policy and Financing
  • IHR Coordination, Communication and Advocacy
  • Antimicrobial Resistance
  • Zoonotic Disease
  • National Laboratory System
  • Surveillance
  • Reporting
  • Human Resources
  • Emergency Preparedness
  • Emergency Response Operations
  • Linking Public Health and Security Authorities
  • Points of Entry
  • Biosafety and Biosecurity
  • Immunization
  • Medical Countermeasures and Personnel Deployment
  • Risk Communications
  • National Laboratory System
  • Biosafety and Biosecurity
  • National Laboratory System
  • Surveillance
  • Reporting
  • Human Resources
  • Risk Communications
  • Points of Entry
  • Zoonotic Disease
  • Biosafety and Biosecurity
  • Zoonotic Disease
  • National Legislation, Policy and Financing
  • Immunization
  • Risk Communications
  • IHR Coordination, Communication and Advocacy
  • Human Resources
  • Immunization
  • National Laboratory System
  • Antimicrobial Resistance
  • Surveillance
  • National Legislation, Policy and Financing
  • Risk Communications
  • Medical Countermeasures and Personnel Deployment
  • Linking Public Health and Security Authorities
  • Emergency Response Operations
  • Emergency Preparedness
  • Human Resources
  • Reporting
  • Surveillance
  • National Laboratory System
  • Biosafety and Biosecurity
  • Zoonotic Disease
  • IHR Coordination, Communication and Advocacy
  • National Legislation, Policy and Financing
  • Points of Entry
  • Human Resources
  • Reporting
  • Surveillance
  • National Laboratory System
  • Biosafety and Biosecurity
  • Zoonotic Disease
  • Antimicrobial Resistance

0

Bilateral & Multilateral Donors

16

Technical Area Supported

0

Implemented Activities

Public Health Emergencies Preparedness
  • PIP Framework
  • UK Health Security Agency (UKHSA)
  • Japan International Cooperation Agency (JICA)

  • To establish and strengthen influenza surveillance systems, knowledge and capacities for a timely and appropriate response to pandemic influenza

  • To support Africa Centres for Disease Control and Prevention (Africa CDC) with the COVID-19 pathogenic genomic sequencing initiative

  • Support Africa Centres for Disease Control and Prevention (Africa CDC) with the distribution of COVID-19 vaccines across the continent

  • To support the UK's New Variant Assessment Platform (NVAP) rollout to African Union Member States, to enhance the detection and subsequent assessment of SARS-CoV-2 variants

  • The research and development capacity of the Gabonese research center is enhanced through the collaborative research with Japanese research institute regarding identification of pathogens of known and unidentified infectious diseases as well as development of rapid diagnostic methods for viral diseases of public health concern. 

  • Support Africa Centres for Disease Control and Prevention (Africa CDC) to undertake a rapid mortality survey to assess the impacts from COVID-19

  • Support Africa Centres for Disease Control and Prevention (Africa CDC) and partners response to Covid-19

  • Support Africa Centres for Disease Control and Prevention (Africa CDC) to develop and strengthen the Africa CDC Kofi Annan Global Health Leadership Programme

  • Support Africa Centres for Disease Control and Prevention (Africa CDC) to develop monitoring and evaluation of the Partnership to Accelerate COVID-19 Testing: Trace, Test and Track initiative

  • Support Africa Centres for Disease Control and Prevention (Africa CDC) with the organisation and delivery of the Africa CDC virtual conference 'Africa's Leadership in COVID-19 Vaccine Development and Access'

  • Support Africa Centres for Disease Control and Prevention (Africa CDC) and partners to develop guidance for sero-surveillance surveys

  • Support Africa Centres for Disease Control and Prevention (Africa CDC) and partners to develop and strengthen the African Volunteer Health Corps (AVoHC) for effective public health deployment for COVID-19 response

  • To support Africa Centres for Disease Control and Prevention (Africa CDC) with the development and implementation of COVID-19 guidance

  • "To support Africa Centres for Disease Control and Prevention (Africa CDC) in strengthening the Public Health Emergency Operation Centres (PH EOC) for effective COVID-19 response across the African Union member states. "

Partner Matching
  • National Legislation, Policy and Financing
  • IHR Coordination, Communication and Advocacy
  • Zoonotic Disease
  • Food Safety
  • Immunization
  • Antimicrobial Resistance
  • Biosafety and Biosecurity
  • National Laboratory System
  • Real-Time Surveillance
  • Reporting
  • Workforce Development
  • Preparedness
  • Emergency Response Operations
  • Medical Countermeasures
  • Risk Communication
  • Points of Entry (PoEs)
  • Chemical Events
  • Radiation Emergencies
  
  • The Global Fund
  • World Bank
AMR support activities
WHO Collaboration Centre

WHO counts on the support of over 800 collaborating centres to do its mandated work and implement its programmes. To find out what these WHO collaborating centres are and their area of work with WHO please visit the database. You can also learn more about the WHO collaborating centres here.

WHO Collaborating Centres

Resource Mapping (REMAP)

Status:

Completed

01-Dec-2021
Overview